Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 3Ovarian Neoplasms 2Breast Neoplasms 2Solid Tumors 1Locally Advanced or Metastatic Solid Tumors 1Glioblastoma 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 4toripalimab 1efineptakin alfa 1MK 2206 1Injections 1Cetuximab 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Locally Advanced or Metastatic Solid Tumors × MK 2206 × Clear all
NCT01021748 2018-08-07

A Combination Therapy Study of MK-2206 and AZD6244 in Participants With Advanced Solid Tumors (MK-2206-010)

Merck Sharp & Dohme LLC

Phase 1 Completed
63 enrolled 17 charts
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡